Unlocking the Potential of Joint Clinical Assessment (JCA) in Europe: Insights from Industry Leaders and Experts
In the ever-evolving landscape of healthcare, ensuring timely access to innovative therapies is a top priority. One promising approach that holds the potential to expedite patient access is the Joint Clinical Assessment (JCA). JCA aims to harmonize the evaluation and decision-making processes for new interventions across European member states, streamlining the path from development to market.
Cencora recently hosted a compelling session at ISPOR Europe 2023 titled 'How to Prepare for JCA in Local Health Systems? Ensuring HTA, Payer, and Industry Readiness to Accelerate Patient Access to Innovation.', with industry experts Herbert Altmann, Head of Market Access Commercialization at Cencora, and Matias Olsen, Senior Manager at the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), shedding light on the challenges and opportunities associated with JCA implementation.
To delve deeper into this crucial topic and gain valuable insights from these thought leaders, The Evidence Base asked them to provide further reflections on JCA readiness from both industry perspective as well as member states and HTA bodies.
Access the full article here to learn more about the various aspects critical to successful JCA implementation. Explore key considerations such as harmonizing clinical evidence submission across member states, reorganizing company functions for enhanced collaboration, mitigating duplication of bureaucracy and workload among HTA bodies, involving patients in a meaningful way throughout the process, ensuring transparency in PICO scoping procedures, and preparing for local healthcare system engagement during JCA.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.